文獻分享：異核復合物具有抗轉(zhuǎn)移和抗血管生成活性

文獻摘要

4.1. Materials and methods

RuCl3·nH2O (J&K), bpy (J&K), phen (J&K), DIP (J&K), 5,6-diamino-1,10-phenanthroline (Alfa  Aesar), 1,10-phenanthroline-5,6-dione (Alfa Aesar), Re(CO)5Cl (Sigma Aldrich), NH4PF6 (Alfa Aesar),  DPBF (Alfa Aesar), MB (Alfa Aesar), Dulbecco's Modified Eagle Medium (DMEM, Gibco), Roswell  Park Memorial Institute 1640 (RPMI 1640, Gibco), fetal bovine serum (Gibco), penicillin-streptomycin  (Gibco), MTT (J&K), JC-1 Detection Kit (Beyotime), H2DCFDA (J&K), Hoechst 33342 (J&K),  Annexin V-FITC Apoptosis Detection Kit (Beyotime), Matrigengel (ABW). Primary antibodies against  caspase-3, PARP, MMP-2, MMP-9 and VEGFR2 were purchased from Cell Signaling Technology.  RuRe1–3 were dissolved in DMSO (1%, v/v) just before the biological experiments.  

發(fā)表時間：2022年12月1日
 IF：4.336
 文章引用產(chǎn)品：MG&ABW Matrigengel
 
作者單位：
昆明理工大學生命科學與技術(shù)學院
云南師范大學化學化工學院
 
原文鏈接：
https://doi.org/10.1016/j.jinorgbio.2022.112090（需復制到網(wǎng)頁查看）

以下為引用�；�（ABW）基質(zhì)膠文獻